Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Entrepreneur Type: Legacy

Monteris

Ceterix

Metavention

Zyga

Vytronus

Vesper Medical

Veran

Vertiflex

Ulthera

Topera

SequentMedical

Senseonics

Respicardia

Relievant

PGDx

Nuvaira

Neuwave

Lutonix

Intact

Inari

Fire1

EPIX

Cvingenuity

ClarVista

ChromeCoda

Cartiva

Cameron Health

CardiAQ

17

Novel FDA PMA & de novo 510k approvals

40

U.S. Commercial Product Launches

34

Level I Clinical Trials

25

Strategic Financings

26

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠

Ready to change healthcare together?

Get in Touch

Our Latest

See All News
NVCA Policy Pulse: Medical Device Coverage Reform with Vensana’s Justin Klein & Kirk Nielsen
Personal Genome Diagnostics Announces Close of $103 Million Series C Financing
Webinar: How Medtech Can Sustain Its Momentum in 2021: Strategies for Successful Investment, Co-Moderated by Justin Klein
Resources
News LP Access
Contact
info@vensanacap.com 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2021 Vensana Capital Management, LLC | Privacy | Terms & Conditions